MannKind Corporation
Organization details
- Legal name
- MannKind Corporation
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Danbury
- Headquarters state / province
- Connecticut
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- MNKD
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000899460
- EIN
- 13-3607736
- Wikidata ID
- Q6750663
Board of directors
-
Anthony C. Hooper · DirectorSince 2023
-
Christine Mundkur · DirectorSince 2023
-
James Samuel Shannon · DirectorSince 2023
-
Jennifer Grancio · DirectorSince 2023
-
Kent Kresa · DirectorSince 2023
-
Michael A. Friedman · DirectorSince 2023
-
Michael Castagna · Director · Chief Executive OfficerSince 2023
-
Ronald J. Consiglio · DirectorSince 2023
-
Sabrina Kay · DirectorSince 2023
-
Steven B. Binder · DirectorSince 2024
Chief executives
Director election results
Annual meeting of May 20, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
90.4%
-
90.8%
-
91.5%
-
91.8%
-
91.8%
-
92.1%
-
92.1%
-
92.5%
-
92.6%
Board connections
5 of this board's directors also sit on 7 other boards. 4 are in the same sector.
-
BeOne Medicines Ltd. Same sectorvia Anthony C. Hooper
-
Cardinal Health Inc. Same sectorvia Christine Mundkur
- via Sabrina Kay
- via Sabrina Kay
- via Kent Kresa
-
ProQR Therapeutics N.V. Same sectorvia James Samuel Shannon
-
Xilio Therapeutics Inc. Same sectorvia James Samuel Shannon
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $259,000
- 1 purchase by 1 insider
- Sold, last 12 months
- $3,255,746
- 14 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 25, 2026 | Steven B. Binder Director | Open-market sale | −39,051 | $3.29 | $128,478 |
| Sep 10, 2026 | Steven B. Binder Director | Open-market sale | −33,558 | $3.81 | $127,856 |
| Aug 7, 2026 | Steven B. Binder Director | Open-market sale | −39,051 | $4.06 | $158,547 |
| Jul 17, 2026 | Steven B. Binder Director | Open-market sale | −52,485 | $4.06 | $213,089 |
| Jul 17, 2026 | Thomson David Officer (EVP Genl Counsel & Secretary) | Open-market sale | −24,109 | $4.05 | $97,641 |
| Jul 15, 2026 | Steven B. Binder Director | Option exercise | +93,790 | — | — |
| Jul 15, 2026 | Michael Castagna Director, Officer (Chief Executive Officer) | Option exercise | +350,260 | — | — |
| Jul 15, 2026 | Thomson David Officer (EVP Genl Counsel & Secretary) | Option exercise | +93,790 | — | — |
| Jul 15, 2026 | Singh Sanjay R Officer (EVP Technical Operations) | Option exercise | +70,550 | — | — |
| Jul 15, 2026 | Tross Stuart A Officer (Chief People & Workpl Officer) | Option exercise | +93,790 | — | — |
| Jul 15, 2026 | Marasco Dominic Officer (Pres, Endocrine Business Unit) | Shares withheld for tax | −3,623 | $4.09 | $14,818 |
| Jul 15, 2026 | Prentiss Christopher B Officer (Chief Financial Officer) | Shares withheld for tax | −11,572 | $4.09 | $47,329 |
| Jul 15, 2026 | Steven B. Binder Director | Shares withheld for tax | −15,688 | $4.09 | $64,164 |
| Jul 15, 2026 | Michael Castagna Director, Officer (Chief Executive Officer) | Shares withheld for tax | −192,819 | $4.09 | $788,630 |
| Jul 15, 2026 | Thomson David Officer (EVP Genl Counsel & Secretary) | Shares withheld for tax | −51,632 | $4.09 | $211,175 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about MannKind Corporation
Who is the CEO of MannKind Corporation?
Michael Castagna is MannKind Corporation's Chief Executive Officer.
How many directors are on MannKind Corporation's board?
MannKind Corporation's board has 10 directors: Anthony C. Hooper, Christine Mundkur, James Samuel Shannon, Jennifer Grancio, Kent Kresa, Michael A. Friedman, Michael Castagna, Ronald J. Consiglio, Sabrina Kay and Steven B. Binder.
Are MannKind Corporation insiders buying or selling shares?
Over the last 12 months, MannKind Corporation insiders bought $259,000 of shares in 1 purchase and sold $3.3 million of shares in 14 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="mannkind-corporation"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.